Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Journal of Medical Research ; (12): 108-111, 2018.
Article in Chinese | WPRIM | ID: wpr-700965

ABSTRACT

Objective The purpose of this study was to examine possible associations of serum levels of cortisol and dehydroepiandrosterone-sulfate (DHEA-S) with psychiatric symptoms in men with chronic schizophrenia.Methods This study involved 120 men with schizophrenia and 110 age-matched healthy controls,and the information of patients were collected on demographic characteristics,age at disease onset,disease duration,positive and negative syndrome scale (PANSS) scores,and history of atypical antipsychotic treatment.Results Serum levels of cortisol and DHEA-S were calculated,as well as the ratios of the two levels.Possible correlations were explored between these levels and psychiatric symptoms before and after antipsychotic treatment.Serum levels of cortisol and DHEA-S levels as well as the ratios of cortisol to DHEA-S levels were more higher in patients than in controls (P < 0.01).Among patients,serum levels of cortisol and DHEA-S were significantly lower after treatment than before (P < 0.01),although the ratios of cortisol to DHEA-S levels remained similar.Serum levels of cortisol,DHEA-S and the ratios of the two levels were positively correlated with the negative symptoms score on the PANSS.Conclusion The pathophysiology of schizophrenia may involve in the spread levels of cortisol and DHEA-S.These levels may serve as biomarkers for diagnosing schizophrenia and monitoring treatment efficacy.

SELECTION OF CITATIONS
SEARCH DETAIL